drugset / Trial / NCT05131997
A Study to Evaluate the Efficacy and Safety of AD-221 and AD-221A
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of AD-221 and AD-221A
Timeline
- Start
- 2021-11-16
- Primary completion
- 2022-06-08
- Completion
- 2022-06-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AD-221 | Unknown | — | — |
| Subject | AD-221A | Unknown | — | — |
| Comparator | Atorvastatin | Small molecule | — | — |
| Comparator | Ezetimibe | Unknown | — | — |